People: Ab Science SA (ABS.PA)

ABS.PA on Paris Stock Exchange

8.69EUR
11:35am EDT
Price Change (% chg)

€0.04 (+0.46%)
Prev Close
€8.65
Open
€8.78
Day's High
€8.78
Day's Low
€8.64
Volume
16,187
Avg. Vol
63,107
52-wk High
€22.30
52-wk Low
€7.16

Search Stocks

Summary

Name Age Since Current Position

Alain Moussy

2001 Chairman of the Board, Chief Executive Officer

Laurent Guy

Chief Financial Officer

Albert Ahn

President - USA region

Tom Chapuis

Commercial Director Europe

Jean-Pierre Kinet

2001 Director

Patrick Moussy

2001 Director

Guy Paillaud

2005 Director

Pierre Chambon

2009 Independent Director

Bertrand de Talhouet

49 2007 Independent Director, representing Bioparticipations

Biographies

Name Description

Alain Moussy

Mr. Alain Moussy has served as the Chairman of the Board and Chief Executive Officer of AB Science since July 11, 2001. He is an engineer (ENSTA), and holds a Master of Business Administration degree from Wharton University since 1993. He is a former strategic consultant at Booz, Allen & Hamilton and former head of Corporate Development at Carrefour. He is currently the Chairman of AFIRMM, association of mastocytosis patients, and President of AMY SAS.

Laurent Guy

Mr. Laurent Guy serves as the Chief Financial Officer of AB Science SA. He has business and finance education. He gained his Master of Business Administration degree from Universite Paris Dauphine. He had a career in the banking industry at Societe Generale and Paribas and in strategy consulting at Accenture. He joined the Company in 2002.

Albert Ahn

Mr. Albert Ahn serves as President for USA region at AB Science SA. He is a Veterinary Medicine Doctor (VMD), and Certified in Internal Medicine. He is the former Managing Director of Summit Vetpharm in the United States.

Tom Chapuis

Mr. Tom Chapuis serves as the Commercial Director Europe of AB Science SA. He is a Doctor in Veterinary Medicine (DVM) and holds a Master of Business Administration degree from HEC. Former General Manager of Mexico and Central America for Servier and former International Marketing Director of Vetoquinol.

Jean-Pierre Kinet

Mr. Jean-Pierre Kinet has served as a Director of AB Science SA since July 11, 2001. He is also the Chairman of the Company's Nominating and Remuneration committee and Co-Chairman of the Scientific committee. He is a Doctor and Professor of Pathology at Harvard Medical School, and Director of the Immunology and Allergy laboratory at Beth Israel Deaconess Medical Center. He is also a Director of UCB Pharma, Genewave and Qualist, and Chairman of Theravectys, IXlife and Vaxon. In addition to that, he is a Member of international committees, including the panel of experts from the National Institutes of Health (NIH) in the United States. He has experience in research and development of molecules.

Patrick Moussy

Mr. Patrick Moussy serves as Director at AB Science SA since July 11, 2001. He is also the Commercial Director of Etablissement Blin. He is an Engineer graduated from ENSCI - Les Ateliers (Ecole Nationale Superieure de Creation Industrielle) and a pilot instructor.

Guy Paillaud

Mr. Guy Paillaud has served as a Director of AB Science SA since June 29, 2005. He is also the Chairman of the Company's Finance Committee. He is the Chairman of Befive, Beviguen and Neptis, Director of Ceprodi, Cold Pack System, Wagram Finance and Alizeo. He graduated from the Universite Paris Dauphine, holds an Executive Master of Business Administration degree from HEC and is a Certified Public Accountant. He is a former Deputy Finance director of Promodes Group.

Pierre Chambon

Mr. Pierre Chambon has served as an Independent Director of AB Science SA since December 31, 2009. He is also a Member of the Company's Scientific committee. He is a doctor, biochemist, geneticist, Member of the Academy of Science, honorary professor at College de France, Director of l'Institut Clinique de la Souris (ICS), and elected to the National Academy of Sciences in the United States. In 1979, he received a Gold medal of the CNRS, and in 2004 the Lasker award for fundamental medical research, for the discovery of a nuclear receptor binding hormones, vitamins and other molecules involved in cell signaling.

Bertrand de Talhouet

Mr. Bertrand De Talhouet has served as an Independent Director of AB Science SA, representing Bioparticipations, since December 21, 2007. He is a graduate of Ecole Polytechnique and a Public Finance Auditor. He is the former Chief Executive Officer (CEO) of La Redoute and the current CEO of Creadev. He is also a Director of Voltalia Investissement, Helexia Development and Voltalia, Chairman of the Board of Directors of Helexia; Permanent representative of Creadev as Member of the Supervisory Board of Ceprodi and Groupe Maisons de Famille, and as Member of the Board of Mauna Kea Technologies SAS, and CEO of Crehol.

Basic Compensation

Search Stocks